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TAAR1 AGONISM BLOCKS COMPULSIVE EATING 
ADAM DAVID HOWELL 
ABSTRACT 
Binge eating disorder (BED) is characterized by compulsive consumption 
of food within a short time period accompanied by loss of control over eating. 
Recent literature provides the basis for consideration of BED as an addiction-like 
disorder. In this study, we aimed to determine the effects of Trace Amine-
Associated Receptor 1 (TAAR1) agonism on maladaptive forms of feeding 
behaviors. TAAR1 is an intracellular receptor preferentially expressed in 
monoaminergic cells, and involved in reward and motivation. For this purpose, 
we trained male rats to self-administer either a sugary, highly palatable diet 
(Palatable rats) or a chow diet (Chow rats) for 1 hour/day under a Fixed Ratio 1 
(FR1) schedule of reinforcement. Following escalation and stabilization of binge-
like eating of palatable food, we tested the effects of the TAAR1 agonist 
RO5256390 on i) binge-like eating and eating rate in the FR1 schedule, ii) 
compulsive eating in a light/dark conflict test, iii) food reward using a conditioned 
place preference test, and lastly iv) food seeking behavior using a second-order 
schedule of reinforcement. Results showed that RO5256390 blocked binge-like 
eating, compulsive eating, food reward, and food seeking behavior selectively in 
Palatable rats without affecting Chow controls’ performance. Results provide 
evidence that TAAR1 may be a potential pharmacological target for Binge Eating 
Disorder. 
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INTRODUCTION 
 Binge eating disorder. Binge eating disorder (BED) is the most common 
eating disorder characterized so far (American Psychiatric Association, 2013). 
Binge eating disorder affects more than 10 million people in the United States 
and is distributed broadly across age, gender, and ethnic groups. A well-
demonstrated link between obesity and BED exists, as well as medical and 
psychiatric comorbidities which include diabetes and cardiovascular diseases, 
anxiety and depression (Becker & Grilo, 2015; American Psychiatric Association, 
2013). The lifetime prevalence for this disorder is around 3%, and factoring in 
comorbidities resultant from this disorder makes BED among the most 
debilitating disorders in the field of psychiatry (Milano et al., 2013). Binge eating 
disorder is characterized by excessive consumption of highly palatable foods 
within a short period of time without the use of compensatory behaviors such as 
purging. These symptoms of binge eating disorder culminate in a loss of control 
over eating (Table 1) (American Psychiatric Association, 2013). 
 
Binge eating disorder as an addiction-like disorder. A growing number of 
behavioral and neurobiological findings from both preclinical and clinical studies 
provide evidence that the uncontrollable intake of highly palatable foods can be 
regarded as an addiction-like disorder (Gearhardt, White, & Potenza, 2011; 
Avena, Gearhardt, Gold, Wang, & Potenza, 2012; Gearhardt, Grilo, DiLeone, 
Brownell, & Potenza, 2011; Corwin & Grigson, 2009; D. G. Smith & Robbins, 
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2013; Volkow & O’Brien, 2007; Volkow & Wise, 2005). In this context, binge 
eating disorder, compared to other disorders of feeding, exhibits the most similar 
diagnostic criteria to drug addiction (Gearhardt, White, et al., 2011; D. G. Smith & 
Robbins, 2013; Meule, 2011). Many analogies between drug addiction and binge 
eating disorder have been drawn, including excessive drug/food intake, loss of 
control over intake, enhanced sensitivity to drug/food conditioned cues, and 
compulsivity exhibited as inability to terminate drug use/overeating despite 
adverse consequences (Iemolo et al., 2012; Geliebter & Aversa, 2003; Parylak, 
Koob, & Zorrilla, 2011; Steiger et al., 2005; Wolfe, Baker, Smith, & Kelly-Weeder, 
2009). 
 
	   3	  
 
Table 1. Binge Eating Disorder Diagnostic Criteria. The Diagnostic and Statistical 
Manual of Mental Disorders (DSM-V) provides this set of criteria for the diagnosis of 
binge eating disorder (Taken from (American Psychiatric Association, 2013)). 
 
 
 
 Development of a multi-symptomatic animal model of binge eating 
disorder. The laboratory has made substantial progress in developing and 
characterizing an operant rat model of binge-like eating, based on a limited 
access to palatable food procedure (Corwin, 2006; Avena et al., 2006; Foltin et 
al., 2008; Hagan et al., 2003), which mimics different maladaptive behavioral 
expressions related to feeding (Cottone et al., 2012; Blasio, Steardo, Sabino, & 
Cottone, 2014; Velázquez-Sánchez et al., 2014).. This operant rat model of 
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binge-like eating is based on a 1 hour per day limited access to a highly 
palatable, sucrose diet (Blasio et al., 2014; Cottone et al., 2012; Velázquez-
Sánchez et al., 2014). This model pairs the action of the rat poking their nose 
through a swinging gate with the illumination of a light overhead and the delivery 
of food. The phenotype observed is “multi-symptomatic” (Belin & Deroche-
Gamonet, 2012), as rats with limited access to a palatable diet, compared to 
chow fed rats, show multiple feeding-related excessive behaviors: a) excessive 
food intake and eating rate in a short period of time, b) loss of control over 
feeding, c) increased conditioned food reward, and d) increased food seeking 
behavior. The use of this “multi-symptomatic” animal model has been helpful to 
study the addiction-like dimensionality of binge eating (Belin, Mar, Dalley, 
Robbins, & Everitt, 2008; Belin & Deroche-Gamonet, 2012; Belin, Berson, 
Balado, Piazza, & Deroche-Gamonet, 2011; Deroche-Gamonet, Belin, & Piazza, 
2004; Molander et al., 2011). 
Under these limited access conditions, rats escalate responding for the 
palatable diet up to 4 times compared to control rats responding for a standard 
chow diet (Cottone et al., 2012). In addition, the dramatic escalation of binge 
eating is accompanied by an increase in eating rate.  
Binge eating rats also display a loss of control over food, defined as 
compulsive eating, demonstrated by the persistent consumption of highly 
palatable food in lieu of aversive conditions. This behavior is measured by food 
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consumed in the open field of a light/dark conflict test (Cottone et al., 2012; 
Velázquez-Sánchez et al., 2014).  
 In addition, binge eating rats display increased conditioned food reward. 
Indeed, the development of maladaptive conditioned behaviors is a critically 
important element in the study of addictive disorders. Stimuli conditioned to 
alcohol, drugs of abuse, or food can exert a powerful control over behavior and 
can elicit craving and precipitate relapse/binge (Everitt & Robbins, 2000; 
Robinson, Yager, Cogan, & Saunders, 2014). Analogously, binge eating rats 
show heightened conditioned food reward as compared to controls, when 
evaluated through a conditioned place preference paradigm. In the conditioned 
place preference paradigm, through an associative learning process, contextual 
neutral stimuli acquire rewarding properties that are seen in the absence of the 
reward (Velázquez-Sánchez et al., 2015) and pairing a palatable diet with tactile 
and visual cues can reinforce the rewarding properties of the food (Velázquez-
Sánchez et al., 2015). 
 Seeking behavior as demonstrated through a second order schedule of 
reinforcement has also been shown as a relevant measure for maladaptive 
behaviors based on stimuli associated with palatable food (Velázquez-Sánchez 
et al., 2015). It has been shown that rats undergoing the binge-like eating 
procedure respond approximately 4 to 6 times more in comparison to control 
rats. The second order schedule of reinforcement is commonly used as a 
measure of seeking behavior for food and drugs of abuse where responding is 
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maintained through both the primary reinforcer as well as the contingent 
presentation of food-paired stimuli that serve as conditioned reinforcers of 
instrumental behavior (Velázquez-Sánchez et al., 2015; Everitt & Robbins, 2000; 
Giuliano, Robbins, Nathan, Bullmore, & Everitt, 2012). 	  
Trace Amines and the TAAR1 Receptor. Trace amines have been known 
and studied, at the time of this writing, approximately for four decades. In 1971, 
Boulton used the term “microamines” to detail the minute level to which these 
molecules exist in comparison to the more common biogenic amines, especially 
in the brain where concentrations observed were <10nM,. As we know them 
today, the function and understanding of “trace amines’”, term first coined in 1975 
by the American College of Neuropsychopharmacology (Usdin & Sandler, 1976), 
continue to represent an emerging area of research (Miller, 2011).  
 In 2001, the discovery of a unique and selective target for trace amines 
reignited the interest and potential of these molecules (Borowsky et al., 2001; 
Bunzow et al., 2001). Further investigation led to the discovery of fifteen Trace 
Amine-Associated Receptors (TAARs), characterized as G protein-coupled 
receptors (GPCRs) (Borowsky et al., 2001). After the identification and cloning of 
all the TAARs known, including 14 in rats and 4 in humans, only two were 
demonstrated to bind and/or be activated by biogenic amines (Miller, 2011). 
Initial studies of TAAR1 in humans focused on the potency with which various 
trace amines activate the receptor of interest (Borowsky et al., 2001). The plot 
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then substantially thickened later in 2001, when Bunzow et al. reported the 
cloning of rat TAAR1 (Bunzow et al., 2001). Among the most important findings 
of this research group was the discovery that the TAAR1 receptor was activated 
by a substantial variety of agonists, including not only trace amines but also 
dopamine and dopamine analogs, drugs which target dopamine, adrenergic and 
serotonergic receptors, as well as ergolines and amphetamine-like drugs of 
abuse (Bunzow et al., 2001). This novel finding secured the credibility of TAAR1, 
a GPCR rather than a monoamine transporter, as a molecular target in the brain 
for drugs of abuse. The next step taken in the understanding of TAAR1 was the 
cloning of the receptor in rhesus monkeys, due to this species close evolutionary 
proximity to humans (Miller et al., 2005). Sequence homology between rhesus 
monkey TAAR1 and human TAAR1 demonstrated a 96% overlap, compared to 
the approximately 76% similarity found between rat TAAR1 and human TAAR1. 
A barrier to precise characterization of TAAR1 was its low extracellular plasma 
membrane expression, as noted by multiple research groups studying various 
model systems (Bunzow et al., 2001; Miller et al., 2005; Xie et al., 2008).  
 
The finding that trace amine levels in the brain were elevated among 
individuals diagnosed with depression and related neuropsychiatric disorders 
stimulated the interests of researchers on the topic (Coppen et al., 1965; A. A. 
Boulton, 1976; O’Reilly et al., 1991; Branchek & Blackburn, 2003; Berry, 2004). 
Further research demonstrated the intimate involvement of trace amines not only 
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in the aforementioned neuropsychiatric arena, but also with regard to brain 
reward circuitry. Relevant in the context of addictive behaviors, trace amines 
have been demonstrated to modulate the rewarding and reinforcing properties of 
psychostimulants (Gilbert & Cooper, 1983; Risner & Jones, 1977; Sandler & 
Reynolds, 1976; H. E. Shannon & Thompson, 1984; Stein, 1964). For example, 
in self-administration paradigms using cocaine, a potent psychostimulant, TAAR1 
agonism led to the dose-dependent attenuation of responding (Pei et al., 2015). 
This result is overtly interpreted as both a decrease in the motivation to respond 
for the drug, as well as a decrease in the reinforcing properties of cocaine 
(Veeneman et al., 2012; Pei et al., 2015). In addition, agonism of TAAR1 
prevented the lowering of reward thresholds in the intracranial self-stimulation 
paradigm known to occur with cocaine administration, which can be interpreted 
as the reduction of the rewarding effect of cocaine through the activation of 
TAAR1 (Pei et al., 2015). 
 
AIMS OF THE STUDY 
 In this study, we aimed to determine the effects of TAAR1 agonism as a 
pharmacological intervention for maladaptive forms of feeding behaviors, through 
the following specific aims: 
 Aim 1 tests the hypothesis that TAAR1 agonist RO5256390 decreases 
binge-like eating of palatable food and eating rate in a fixed ratio 1 schedule of 
reinforcement; 
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 Aim 2 tests the hypothesis that TAAR1 agonist RO5256390 decreases 
compulsive eating of highly palatable food in the presence of overt and aversive 
conditions, in a light/dark conflict test; 
 Aim 3 tests the hypothesis that TAAR1 agonist RO5256390 blocks 
conditioned food reward in a conditioned place preference task; 
 Aim 4 tests the hypothesis that TAAR1 agonist RO5256390 decreases 
seeking behavior for palatable food in a second-order schedule of reinforcement.  
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MATERIALS AND METHODS 
Subjects 
 
 We began with forty-eight male Wistar rats, 45 days old upon arrival 
(Charles River, Wilmington, MA). For the behavioral experiments, all animals 
were housed in a temperature and humidity controlled (22°C, 60%) colony room 
with a 12-h light/dark cycle (lights off at 11 a.m.). Rats were given ad libitum 
access to water and AIN-76A-based diet, hereafter referred to as ‘Chow A/I’ 
(5TUM diet formulated as 4–5  g extruded pellets, 65.5% (kcal) carbohydrate, 
10.4% fat, 24.1% protein, 330  cal/100  g; TestDiet, Richmond, IN).  
 
Apparatus for self-administration procedures 
 All experimental sessions were conducted in individual operant chambers 
(Med Associates Inc., St. Albans, VT). Each operant test chamber (30×24×29 
cm) had a stainless steel grid floor and were located in ventilated, sound-
attenuating enclosures (66×56×36 cm) as described (Blasio et al., 2014; Cottone 
et al., 2012). Food reinforcers were delivered by a pellet dispenser into a nose-
poke aperture and water reinforcers (100 microliters in volume) were delivered by 
a solenoid into a liquid cup nose-poke receptacle located adjacent to the pellet 
receptacle. 28-V stimulus cue-lights were located above the food magazine. The 
delivery of a pellet was paired with a light-cue lasting 0.3 sec. All responses were 
recorded automatically by a microcomputer with 10 ms resolution. Procedures 
adhered to the National Institutes of Health Guide for the Care and Use of 
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Laboratory Animals and the Principles of Laboratory Animal Care, and were 
approved by Boston University Medical Campus Institutional Animal Care and 
Use Committee. 
 
Drugs 
 For systemic administration, RO5256390 (TAAR1 agonist) synthesized at 
F. Hoffmann-La Roche Ltd. (Basel, Switzerland) was dissolved in 0.3% Tween 
80 and 0.9% saline immediately before administration (Pei et al., 2015). For 
within-subject experiments, treatment days were separated by 1–3 intervening 
days until the variables returned to baseline. Doses, injection volume, suitability 
of the vehicle, and pretreatment times were based on previously published 
reports (Pei et al., 2015; Pei et al., 2014; Revel et al., 2012).    
 
Operant model of binge-like eating in rats  
 After 3 days of habituation to the Chow A/I diet in their home cages, rats 
began daily training to self-administer food pellets (45-mg precision food pellets 
(Chow A/I)) during 1-hour experimental sessions under a Fixed Ratio 1 (FR1) 
schedule of reinforcement. After all rats demonstrated stable responding during 
the daily 1 hour FR1 sessions, they were matched on body weight, average 
pellet responses, and average water responses based on data from the previous 
three experimental sessions. Half of the rats were assigned to the ‘Chow’ group, 
and the other half to the ‘Palatable’ group. For operant sessions after the groups 
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were assigned, Chow animals received pellets identical to those offered during 
the training phase. Palatable animals received a nutritionally complete, 
chocolate-flavored, high-sucrose (50% kcal) AIN-76A-based diet, comparable in 
macronutrient composition and energy density to the chow diet (chocolate-
flavored Formula 5TUL: 66.7% (kcal) carbohydrate, 12.7% fat, 20.6% protein, 
metabolizable energy 344  cal/100  g; formulated as 45-mg precision food pellets; 
TestDiet, Richmond, IN). As previously demonstrated, rats have a strong 
preference for a chocolate-flavored diet (Cottone et al., 2008, 2009). Rats 
underwent to 1h daily sessions for at least 12 days to allow the escalation and 
stabilization of the palatable food intake under a Fixed Ratio 1 schedule of 
reinforcement. When the intake remained stable for the 3 experimental sessions, 
animals were injected with the full TAAR1 agonist RO5256390 (0, 1, 3 or 10 
mg/kg, i.p), 30 min prior to the operant sessions, following a within-subjects 
Latin-square design. 
 
High rate of responding for Chow A/I induced by food restriction 
 To increase the rate of responding for Chow A/I during the operant self-
administration sessions, rats were food restricted in their home cages. For this 
purpose, 7 grams of Chow A/I food was provided in the home cages at the end of 
the operant self-administration sessions so that the total daily intake, including 
the food consumed during the self-administration session, was the 70% of a rat 
daily intake. This expedient was used to: i) ensure that the rats consumed the 
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entire home cage food intake before the beginning of the following self-
administration session, ii) induce an energy homeostatic overeating in the 
operant self-administration sessions and, therefore, iii) increase the rate of 
responding for the Chow A/I diet in the operant self-administration sessions. 
Under these experimental conditions, the rate of responding for the Chow A/I diet 
of food-restricted rats was comparable to the rate of responding for the highly 
palatable sugary diet of ad libitum-fed Palatable rats. Animals were food 
restricted for 14 days before they injected with the full TAAR1 agonist 
RO5256390 (0 or 10 mg/kg, i.p), 30 min prior to the operant sessions, following a 
within-subjects Latin-square design. 
 
Rate and regularity of sustained eating: inter food interval analysis 
To identify differences between Chow vs. Palatable rats in the rate and 
regularity of sustained (not interrupted by drinking) eating, analysis of the ln-
transformed duration of consecutive (uninterrupted by drinking) inter food 
intervals was performed (Cottone et al., 2012). Inter food interval is a variable 
inversely correlated to eating rate. The mean, entropy, kurtosis, and skewness of 
the ln-transformed duration of each subject’s consecutive inter food intervals was 
individually determined and then averaged across subjects. The normalized 
frequency histogram entropy (H) is a measure of categorical variability in the rate 
of ingestion (C. E. Shannon & Weaver, 1949). For entropy analysis, histograms 
were constructed from ln-transformed inter food intervals that fell from e-1 to e3 
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sec (~0.34-20.1 sec), with a bin width of e0.2. Significant decreases in the mean 
indicate an increased eating rate. Significant increases in the histogram entropy 
(a measure of categorical variability, reflected in an increasing number of 
populated histogram bins, each with more similar event frequencies), indicate a 
decreased regularity of intake. Conversely, a decrease in the kurtosis of the inter 
food interval distribution (a measure of the distribution's 'peakedness', reflected in 
a flatter top and taller tails of the distribution), is consistent with a decreased 
regularity of pellet-to-pellet feeding. Finally, a significant increase in the 
skewness (a measure of the distribution’s symmetry, reflected in a selective 
increase of the frequency of the inter food interval falling to the left of the 
histogram) is consistent with a selective increase of the fast pellet-to-pellet 
responding. 
 
Light/Dark Conflict Test 
 This test was composed of an arena with two distinct chambers connected 
by a small aperture to allow the rat to freely pass between the two chambers. 
One chamber is open and brightly lit to approximately 60 lux, while the other 
chamber is composed of opaque walls and ceiling, thereby providing essentially 
dark conditions (Teegarden & Bale, 2007). A pre-weighed amount of the same 
food received during self-administration (45-mg Chow A/I pellets for Chow rats or 
45-mg chocolate pellets for Palatable rats) was positioned in the center of the 
light compartment. The 10-minute test begins by placing the rat in the lighted 
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compartment facing the food cup, as well as the aperture into the dark 
compartment. Test measurements taken include the time spent in the open 
compartment and the amount of food eaten during the trial. These two dependent 
variables demonstrate the operationalization of ‘risk-taking behavior' and 
‘compulsive-like eating' constructs (Cottone et al., 2012). Since rats view bright, 
aversive environments as potentially dangerous, the time spent exploring the 
light compartment of the arena under normal, control conditions is minimal.  The 
amount of food eaten, compared to control conditions, during the trial was used 
to operationalize ‘compulsive-like eating’, since eating behavior is typically 
suppressed when a rat is in threatening or aversive environments (Cottone et al., 
2012; Teegarden & Bale, 2007). On the test day, animals were habituated in an 
ante-room 2 hours prior to test initiation. Animals were injected with the full 
TAAR1 agonist RO5256390 (0 or 10 mg/kg, i.p), 30 min prior to the testing 
session, following a between-subjects Latin-square design. 
 
Conditioned Place Preference (CPP) Test 
 The conditioned place preference (CPP) apparatus (Med Associates, 
Georgia, VT) consisted of two equal sized outer chambers (27.5×20.6×21.5 cm), 
one black and one white, separated by a smaller center chamber 
(11.9×20.6×21.5 cm) with an automatic guillotine door opening into each 
chamber. The variable of interest for this experiment, time spent in each 
chamber, was measured with IR photobeam detectors. The CPP procedure 
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consisted of three different phases: preconditioning or bias determination, 
conditioning, and post-conditioning. During the pre-conditioning, rats were 
allowed to freely explore the apparatus for 15 minutes. After this phase, each 
animal was assigned a bias reflective of the chamber in which they spent more of 
the preconditioning session time. Subjects were confined on alternate days to 
either their biased chamber with an empty food bowl or to their unbiased 
chamber with a bowl of their respective food (either chow [Chow group] or 
palatable [Palatable group] as previously assigned) (Wang et al., 2014). These 
conditioning sessions were performed daily, lasted for 25 min, and continued for 
8 days in total (four pairings each). 24 hours after the final conditioning session, 
rats were tested following the same procedure as the preconditioning test (post-
conditioning phase). The time spent in each chamber was recorded and CPP 
was determine by calculating a CPP score (time in paired chamber – time in 
unpaired chamber) (Velázquez-Sánchez et al., 2014; Lax, George, Ignatz, & 
Kolber, 2014; Wang et al., 2014; Xue et al., 2014). All animals were habituated in 
an ante-room 1 hour prior to each experimental session for the entirety of the 
experiment. On the post-conditioning testing day, animals were injected with the 
full TAAR1 agonist RO5256390 (0 or 10 mg/kg, i.p), 30 min prior to the testing 
session, following a between-subjects Latin-square design. 
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Second Order Schedule of Reinforcement  
 Food-seeking behavior under a second-order schedule of reinforcement is 
a procedure in which responding is maintained by the contingent presentation of 
food-paired stimuli that serve as conditioned reinforcers of instrumental behavior 
(Everitt & Robbins, 2000; Giuliano et al., 2012). In the second-order schedule of 
reinforcement (FI5(FR10:S)), every 10th active lever press (Fixed Ratio 10, 
FR10) resulted in a brief illumination of lights above both the active lever and the 
food magazine for 1 second. Responses on the inactive lever had no 
programmed consequences but were recorded to assess discriminative 
responding and general levels of motor activity. Following the tenth active lever 
press after a Fixed Interval of 5 min (FI5 min) had elapsed, 20 pellets (45-mg 
chow pellets for Chow rats or 45-mg sucrose pellets for Palatable rats) were 
delivered in the food magazine, both the active and inactive levers retracted, and 
the lights above both the active lever and the food magazine were presented 
during a 20-sec time out. During the FI interval, rats that pressed the active lever 
did not receive any pellets. After the time out, the lights above both the active 
lever and the food magazine turned off and the two levers were again extended 
into the chamber. The second-order schedule of reinforcement session lasted 40 
minutes. This seeking procedure is similar to those previously described (K. L. 
Smith et al., 2015; Velázquez-Sánchez et al., 2014). When the intake remained 
stable for the 3 consecutive experimental sessions, animals were injected with 
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the full TAAR1 agonist RO5256390 (0, 1, 3 or 10 mg/kg, i.p), 30 min prior to the 
operant sessions, following a within-subjects Latin-square design. 
 
Statistical analyses 
Data was analyzed by simple or factorial ANOVAs. Pairwise post-hoc 
comparisons were made using the Fisher’s LSD test. Statistical significance level 
was set at P ≤ 0.05. 
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RESULTS 
Effects of the TAAR1 agonist RO5256390 on operant binge-like eating 
 The Palatable food group consumed significantly more food compared 
with the Chow controls under vehicle conditions (Diet, F1,22=62.72, p≤0.001, 
Figure 1). Systemic RO5256390 treatment selectively and dose-dependently 
 
 
Figure 1.  Effects of the TAAR1 agonist RO5256390 on operant binge-like 
eating. Effects of RO5256390 on food intake during 1-hour self-administration 
session under fixed ratio 1 schedule of reinforcement in male Wistar rats. Bars 
represent mean±SEM. ** p <0.01, ***p <0.001 vs. Vehicle Palatable; ## p<0.01, ### 
p<0.001 vs, Vehicle Chow (Fisher’s LSD post-hoc test).	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blocked the binge-like eating of the Palatable food group in the operant task, 
without affecting intake of the control Chow food group (Dose, F3,66=22.17, 
p≤0.0001; Diet × Dose, F3,66=10.02, p≤0.001). Post hoc analysis showed that 
RO5256390 significantly decreased palatable food responding when injected at 
the doses of 1 and 3 mg/kg as compared with the vehicle-treated Palatable food 
group, and fully blocked binge-like eating when injected at the highest dose used, 
10  mg/kg, as compared to vehicle-injected controls. 
 
Effects of the TAAR1 agonist RO5256390 on food restriction-induced 
binge-like eating 
Responding for regular chow in food-restricted rats was comparable to 
responding of vehicle-treated ad libitum-fed Palatable rats in the RO5256390 
administration FR1 study. Systemic treatment with the 10 mg/kg dose of 
RO5256390 had no effect on the high rate of responding for Chow A/I in the 
operant FR1 food intake task in food-restricted rats (t9=0.95, n.s.; Figure 2). 
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Figure 2.  Effects of the TAAR1 agonist RO5256390 on food restriction-induced 
binge-like eating. Effects of RO5256390 on standard chow responding intake after 
food restriction during 1 hour self-administration session under fixed ratio 1 schedule of 
reinforcement in male Wistar rats. 	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Effects of the TAAR1 agonist RO5256390 on rate and regularity of 
sustained eating 
Palatable rats showed significantly smaller Inter Food Interval (IFI) mean 
compared to control Chow rats (Diet, F1,15=72.68, p≤0.001, Figure 3). Treatment 
with RO5256390 (10 mg/kg, i.p.) significantly increased the IFI mean of Palatable 
 
 
Figure 3. Effects of the TAAR1 agonist RO5256390 on IFI Effects of RO5256390 
on Inter Food Interval (IFI) during 1-hour self-administration session under fixed ratio 
1 schedule of reinforcement in male Wistar rats. Bars represent mean±SEM. *** 
p<0.001 vs. Vehicle Palatable; ### p<0.001 vs. Vehicle Chow (Fisher’s LSD post-
hoc test).	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rats as compared to vehicle condition (Dose, F1,15=10.22, p≤0.01; Diet × Dose, 
F1,15=1.84, n.s.). This effect was selective for rats responding for the palatable 
diet as drug treatment did not affect controls. 
 
 Palatable rats showed significantly smaller entropy compared to control 
Chow rats (Diet, F1,15=88.45, p≤0.001, Figure 4). RO5256390 significantly 
increased entropy in Palatable rats as compared to vehicle condition (Dose, 
F1,15=39.56, p≤0.001; Diet × Dose, F1,15=10.17, p≤0.01). This effect was selective 
for rats responding for the palatable diet as drug treatment did not affect controls. 
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Figure 4.  TAAR1 Agonism Decreases Entropy of IFI distribution. Effects of 
RO5256390 on Entropy during 1 hour self-administration session under fixed ratio 1 
schedule of reinforcement in male Wistar rats. Bars represent mean±SEM. *** p<0.001 
vs. Vehicle Palatable; ### p<0.001 vs. Vehicle Chow (Fisher’s LSD post-hoc test). 
	   25	  
 Palatable rats showed significantly higher kurtosis compared to control 
Chow rats (Diet, F1,15=14.51, p≤0.002, Figure 5). RO5256390 significantly 
decreased kurtosis in Palatable rats as compared to vehicle condition (Dose, 
F1,15=12.17, p≤0.01; Diet × Dose, F1,15=1.15, n.s.). This effect was selective for 
rats responding for the palatable diet as drug treatment did not affect controls. 
 
 
Figure 5.  TAAR1 Agonism Decreases Kurtosis of IFI Distribution. Effects of 
RO5256390 on Kurtosis during 1 hour self-administration session under fixed ratio 1 
schedule of reinforcement in male Wistar rats. Bars represent mean±SEM. ** p<0.01 
vs. Vehicle Palatable; ## p<0.01 vs. Vehicle Chow (Fisher’s LSD post-hoc test). 
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Palatable rats showed significantly higher skewness compared to control 
Chow rats (Diet, F1,15=5.42, p≤0.05, Figure 6). A trend towards reduction of 
skewness following RO5256390 treatment was observed (Dose, F1,15=3.61, 
p=0.07; Diet × Dose, F1,15=4.02, p=0.06). 
 
Figure 6.  TAAR1 Agonism Decreases Skewness of IFI Distribution. Effects of 
RO5256390 on Skewness during 1 hour self-administration session under fixed ratio 
1 schedule of reinforcement in male Wistar rats. Bars represent mean±SEM. ** 
p<0.01 vs. Vehicle Palatable; # p<0.05 vs. Vehicle Chow (Fisher’s LSD post-hoc 
test). 
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Effects of the TAAR1 agonist RO5256390 on compulsive-like eating 
The Palatable food group exhibited compulsive-like-eating behavior, 
consuming more food under vehicle conditions compared with the control Chow 
food group, although the food was placed in a bright, aversive compartment 
(Diet, F1,83=5.34, p≤0.05, Figure 7). RO5256390 treatment selectively blocked 
compulsive-like eating in the Palatable food group when the 10  mg/kg dose was 
administered (Dose, F1,83=10.37, p≤0.002; Diet × Dose, F1,83=4.10, p≤0.05). This 
effect was selective for rats responding for the palatable diet as drug treatment 
did not affect controls. 	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Figure 7. Effects of the TAAR1 agonist RO5256390 on compulsive-like eating. 
Effects of RO5256390 on food intake during the Light-Dark Conflict Test in male 
Wistar rats. Bars represent mean±SEM. ** p<0.01 vs. Vehicle Palatable; ### 
p<0.001 vs. Vehicle Chow (Fisher’s LSD post-hoc test).	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Effects of the TAAR1 agonist RO5256390 on conditioned food reward 
The analysis of the CPP scores during the post-conditioning phase 
indicated that Palatable rats under vehicle conditions spent significantly more 
time in the initially non-preferred compartment, which was paired with the 
palatable food (biased procedure), when compared with their score in the 
preconditioning phase. However, on the test day Palatable rats treated with 
RO5256390 (10 mg/kg, i.p.) did not significantly differ when compared with their 
score in the preconditioning phase, and spent significantly more time in the 
initially preferred compartment, which was not paired with palatable food. (Diet x 
Dose: F1,29=4.19, p≤0.05, Figure 8). 
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Figure 8. Effects of the TAAR1 agonist RO5256390 on conditioned food reward. 
Effects of RO5256390 on Conditioned Place Preference in male Wistar rats. Bars 
represent mean±SEM. * p<0.05 vs. Vehicle Palatable; ## p<0.01 vs. preconditioning 
phase (Fisher’s LSD post-hoc test). 
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Effects of the TAAR1 agonist RO5256390 on food seeking 
Palatable rats showed significantly higher active lever food seeking 
compared to control Chow rats (Diet, F1,14=9.99, p≤0.01, Figure 9). Inactive lever 
responding did not differ between food groups (Diet, F1,14=0.53, n.s.). 
RO5256390 treatment blocked the palatable food-dependent increase in active 
lever responding, without affecting responding in the control Chow food group 
(Dose, F1,83=5.70, p≤0.52; Diet × Dose, F1,83=1.64, n.s.). Treatment did not affect 
inactive lever responding (Dose, F1,83=1.65, n.s.; Diet × Dose, F1,83=0.02, n.s.). 
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Figure 9.  Effects of the TAAR1 agonist RO5256390 on food seeking. Effects of 
RO5256390 on food seeking under a second order schedule of reinforcement in male 
Wistar rats. Bars represent mean±SEM. ** p<0.01 vs. Vehicle Palatable; ##  p<0.01 
vs. Vehicle Chow (Fisher’s LSD post-hoc test). 
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DISCUSSION 
 In this series of studies we show that, the selective agonist of TAAR1 
receptor RO5256390, when systemically administered, selectively and dose-
dependently blocked binge-like eating and reduced eating rate. In addition, drug 
treatment blocked compulsive-like eating, conditioned food reward, and food 
seeking behavior. 
 At all doses tested, 1, 3, and 10 mg/kg, the TAAR1 receptor agonist 
RO5256390 significantly and dose-dependently decreased binge-like eating of 
palatable food as compared to vehicle treated rats.  
Excluding the alternative explanation that the decrease in palatable food 
responding was secondary to an overall behavioral deficit, drug treatment did not 
affect responding for the standard chow diet in control rats. 
In addition, RO5256390, administered at the dose that maximally 
decreased binge-like eating of palatable diet (10 mg/kg), did not affect high rate 
of responding for Chow A/I in food-restricted animals. Therefore, data from the 
food restriction experiment suggest that RO5256390’s effects are specific for 
palatability induced behavioral processes and independent from high rates of 
response. More generally, these findings emphasize the difference between 
hedonic vs. energy-homeostatic control of food intake and confirm the hypothesis 
that although food-related behavioral outcomes induced by palatability can be 
apparently similar to the ones observed following food restriction/deprivation, the 
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two are governed by dissimilar neuroadaptive mechanisms (Corwin, 2006; 
Cottone et al., 2009, 2012). 
Moreover, RO5256390 decreased the rate and the regularity of sustained 
food responding selectively in bingeing rats, but not in chow-fed control rats. 
When compared to standard chow responding, limited access to a sugary diet 
induces characteristic changes in the regularity of pellet-by-pellet responding, 
which are suggestive of a palatability-dependent behavioral process. Indeed, 
binge eating rats show a decreased IFI, which is a validated measure of eating 
rate (Cottone et al., 2012). In addition, responding for the sugary diet in bingeing 
rats increases the skewness of the IFI distribution (a measure of symmetry), 
which represents a selective increase of the frequency of the IFI falling to the left 
of the histogram (Cottone et al., 2012). Moreover, binge eating responding is 
characterized by an increased kurtosis of the IFI distribution (a measure of the 
distribution's 'peakedness', reflected in a more peaked top and smaller tails of the 
distribution), which is interpreted as an increase in the regularity of pellet-to-pellet 
responding (Cottone et al., 2012). Finally, binge eating responding is 
characterized by a decrease in the entropy of the IFI distribution (a measure of 
categorical variability). Significant decreases in entropy, as seen in bingeing rats, 
demonstrate a increased regularity of intake (Cottone et al., 2012). Interestingly, 
RO5256390 treatment blocked the palatability-dependent changes in IFI, 
kurtosis, skewness and entropy. Thus, RO5256390 specifically disrupted the 
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ability of palatable food, but not regular chow, to sustain the strength of pellet-by-
pellet responding. 
 
 At the highest dose tested, 10 mg/kg, RO5256390 blocked compulsive-
like eating behavior. In Chow rats, eating behavior is suppressed when a rat 
faces the adverse circumstances of the bright compartment of the light/dark box; 
therefore, we operationalized the construct of ‘compulsive-like eating’ through the 
significant increase in food intake in spite of the adverse conditions, in Palatable 
rats as compared to controls (Cottone et al., 2012; K. L. Smith et al., 2015; 
Velázquez-Sánchez et al., 2014). Loss of control over food is considered an 
intractable aspect of addiction, resulting in continued use despite many incurring 
negative consequences under which behaviors would typically be suppressed 
(Deroche-Gamonet et al., 2004; Vanderschuren & Everitt, 2004; Piazza & 
Deroche-Gamonet, 2013). In the context of drug addiction, these negative 
consequences encompass incidence of legal issues, loss of personal 
relationships, health consequences, etc.; yet, those afflicted with addiction often 
continue to seek and take drugs (Sussman & Sussman, 2011).. Similarly, 
maladaptive eating behavior can result in medical conditions associated with 
weight gain (e.g. hypertension, type II diabetes, osteoarthritis, cancer), as well as 
psychological and social impairment including emotional problems and 
psychiatric disorders (WHO, 2000; Warschburger, 2005; Klatzkin et al., 2015). 
However, despite many resulting negative consequences of the behavior, the 
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individual finds it very difficult to stop. ‘Loss of control’ is thought to result from 
deficits in inhibitory control mechanisms responsible for the suppression of 
inappropriate actions. These deficits are thought to confer vulnerability to the 
addictive behavior and/or emerge from persistent and prolonged drug use or 
palatable food overconsumption (Lubman et al.,, 2004; Chen et al., 2013; Volkow 
et al.,, 2013) 
 
 In this study, RO5256390 blocked conditioned reward for the palatable 
diet, but not for the standard chow diet, in the conditioned place preference 
paradigm. The conditioned place preference task is used to determine if tactile 
and visual cues associated with a specified diet can acquire the rewarding 
properties of that diet. Rats nosepoking for the palatable diet show a heightened 
conditioned food reward as compared to rats responding for the standard chow 
diet. Our results show that the rewarding properties of palatable food acquired 
through conditioning can be blocked by systemic administration of RO5256390. 
This effect was selective for rats exposed to the palatable diet, as the drug 
treatment did not affect conditioned reward for standard chow diet. 
 
 Our results show that, TAAR1 agonism, through treatment with 
RO5256390, selectively decreases seeking behavior for palatable food in a 
second order schedule of reinforcement. The second order schedule of 
reinforcement is a task commonly used to induce seeking behavior. As 
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previously reported, this schedule of reinforcement is used to maintain seeking 
behavior through both the primary reinforcer and the contingent presentation of 
food-paired stimuli that serve as the conditioned reinforcers of instrumental 
behavior (Everitt & Robbins, 2000; Giuliano et al., 2012; Velázquez-Sánchez et 
al., 2015). We can confidently exclude that this effect was induced by an overall 
behavioral deficit induced by the drug as the effect was selective for active lever 
responding, and did not influence inactive lever responding. In addition, 
responding for a cue associated with the standard chow diet was not affected by 
drug treatment, suggesting that only behaviors driven by stimuli conditioned to 
strong reinforcers are decreased by drug treatment. 
 
 Our results support the role of TAAR1 receptor agonism in decreasing 
addictive-like behaviors. Indeed, in multiple studies TAAR1 agonism has been 
demonstrated to block the rewarding/reinforcing properties of drugs of abuse, 
particularly psychostimulants. Activation of TAAR1 has been shown to decrease 
the reinforcement and reward efficacy of cocaine, while also blocking the 
conditioned place preference for this drug (Pei et al., 2014; Pei et al., 2015; 
Thorn et al., 2014). Furthermore, it has been found that TAAR1 agonism 
attenuates the reinstatement of drug seeking behavior (Pei et al., 2014; Thorn et 
al., 2014).  In addition to these observations, which apply directly to our study, 
TAAR1 agonism has shown to block reward memory, another critical element of 
addictive behaviors (Liu et al., 2016).  
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Conclusions 
 We have shown that administration of the TAAR1 agonist RO5256390 in 
rodents produces favorable effects on multiple maladaptive feeding behaviors 
that mimic the elements of binge eating disorder. Our studies show that TAAR1 
agonism blocks binge-like eating and decreases eating rate. Moreover, we have 
demonstrated that TAAR1 agonism blocks compulsivity for food, a highly 
translational aspect of binge-like eating. Treatment with RO5256390 also blocked 
the strength of environmental cues associated with the highly palatable food in a 
conditioned place preference paradigm. Lastly, we have demonstrated that 
RO5256390 blocks motivation for food operationalized through a seeking 
behavior construct. Taken together, these results substantiate the potential for 
RO5256390 as a pharmacological treatment for Binge Eating Disorder.  
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